RxDoctor Payments DataLook up a doctor →

Kalpesh Patel, MD

Urology · Tucson, AZNPI 1386649911

Payments from drug & device makers

$2,251,213in general payments, 2019–2025

Across 672 payments — averaging $3350.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$733K
  • Provepharm Inc.$426K
  • AstraZeneca$156K
  • Bayer$144K
  • Urogen Pharma, Inc.$122K
  • Ferring Pharmaceuticals AS$121K
  • plus $550K from 49 others
$3,000in research payments, 2019–2025

Across 1 payment — averaging $3000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Provepharm Inc.$3K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck9$732,870
Provepharm Inc.30$426,264
AstraZeneca21$155,650
Bayer46$144,016
Urogen Pharma, Inc.105$121,728
Ferring Pharmaceuticals AS25$120,638
Calyxo, Inc.22$109,439
Janssen Research & Development, LLC47$87,574
Ferring International Pharmascience Center US12$82,644
Veru Inc.21$74,286
Pfizer19$44,444
Astellas Pharma Global Development5$41,072
Olympus Corporation Of The Americas11$40,915
Siemens Medical Solutions USA, Inc.4$31,946
Eli Lilly1$9,188
Olympus America Inc.49$7,414
Neotract Inc.50$4,420
Boston Scientific16$3,235
Gyrus ACMI, Inc.3$3,074
Organon1$2,890
Procept Biorobotics Corporation17$1,499
Lilly USA, LLC1$704
Coloplast15$649
Dornier Medtech America, Inc1$590
Sumitomo Pharma America, Inc.16$463
Axonics, Inc.6$427
AbbVie(2 entities)18$397
Teleflex LLC11$300
Angiodynamics, Inc.5$268
Dendreon Pharmaceuticals LLC7$258
Johnson & Johnson(2 entities)6$243
Astellas Pharma US Inc12$233
Myovant Sciences Inc.11$225
Laborie Medical Technologies Corp.6$197
Myriad Genetic Laboratories, Inc.2$142
Endo Pharmaceuticals Inc.2$136
Ferring Pharmaceuticals Inc.5$101
Amgen5$99
Blue Earth Diagnostics5$98
Sun Pharmaceutical Industries Inc.4$67
Bioprotect Medical, Inc.3$60
Tolmar, Inc.2$56
Novartis2$54
Novo Nordisk1$32
Progenics Pharmaceuticals, Inc.1$27
Intuitive Surgical1$27
Cardinal Health 414 LLC1$24
C. R. Bard, Inc. & Subsidiaries1$23
Agiliti Surgical, Inc.1$20
Koelis Inc.1$18
Verity Pharmaceuticals Inc.1$18
Accord Healthcare, Inc.1$15
Tolmar Pharmaceuticals, Inc.1$15
Cook Medical LLC2$14
GSK1$13

How this compares

$2,251,213 in reported general payments places this provider in the 95th percentile of 269 urology providers in Arizona.

See all urology providers in Arizona →

Medicare billing

Part B allowed, 2024
$313,514
Medicare patients
594
Services billed
5,609

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Tucson

See the full list for Arizona →

Where these figures come from

Is this you, or does something look wrong? →